Originator Organization CKD Bio Corp.SynAffix BVStartup |
Active Organization SynAffix BVStartupCKD Bio Corp. |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | SynAffix BVStartup | 05 Apr 2024 |
Neoplasms | Preclinical | NL | 05 Apr 2024 | |
Neoplasms | Preclinical | KR | SynAffix BVStartup | 05 Apr 2024 |
Neoplasms | Preclinical | KR | 05 Apr 2024 |